Publication date: Mar 26, 2025
By assessing the standard-of-care regimen for tuberculosis (TB) in BALB/c and C3HeB/FeJ mice, we demonstrate that rifampin, with or without pyrazinamide, is essential for an effective bactericidal response and suppression of resistance. Potency measurements in an in vitro lipid-rich model and a rabbit caseum assay recapitulate the significance of rifampin as a sterilizing agent. These outcomes align with clinical performance, thus emphasizing the value of in vitro predictive tools and murine TB models with human-like pathology.
Open Access PDF
Concepts | Keywords |
---|---|
Bactericidal | C3HeB/FeJ |
Clinical | caseum |
Mice | relapse |
Rich | rifafour |
Tuberculosis | tuberculosis |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | bactericidal |
disease | MESH | tuberculosis |
pathway | KEGG | Tuberculosis |
drug | DRUGBANK | Rifampicin |
drug | DRUGBANK | Pyrazinamide |
disease | IDO | assay |
disease | MESH | relapse |
drug | DRUGBANK | Isoniazid |
drug | DRUGBANK | Ethambutol |
disease | IDO | bacteriostatic |
disease | MESH | granulomas |
disease | IDO | susceptibility |
drug | DRUGBANK | Butyric Acid |
disease | IDO | bacteria |
drug | DRUGBANK | Ilex paraguariensis leaf |
disease | MESH | infection |
drug | DRUGBANK | Activated charcoal |
disease | MESH | drug interactions |
pathway | REACTOME | Translation |
drug | DRUGBANK | Etoperidone |
drug | DRUGBANK | Dimethyl sulfoxide |
disease | MESH | Allergy |
disease | MESH | Infectious Diseases |
drug | DRUGBANK | Moxifloxacin |
drug | DRUGBANK | Bedaquiline |
disease | MESH | drug tolerance |
disease | MESH | pulmonary tuberculosis |
drug | DRUGBANK | Carboxyamidotriazole |
Original Article
(Visited 1 times, 1 visits today)